examine.com Peptide Therapy: Ready for Prime Time FxMed
As a specialist knee surgeon in Sydney, Dr Jonathan Negus is comfortable having open conversations about emerging treatments and where they currently fit in evidence-based knee care
BPC-157 / TB-500 is a research peptide blend combining two well-studied synthetic peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 fragment TB-500. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptide modeled after the naturall
Understanding the Connection Between BPC-157 and Blood Pressure Blood pressure regulation involves a complex interplay of hormones, nervous system signals, and blood vessel mechanics
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
doi: 10.1016/j.amjmed.2017.04.043 113